Donate to the IAP Campaign and Help Fund Fair Regulation — 💙 Support Our Work
The Digital Future is Here – But Not for Everyone
In an era where digital transformation is reshaping healthcare delivery, the Health Secretary
Wes Streeting has championed the move from “analogue to digital” healthcare, calling for “a
digital healthcare service powered by cutting-edge technology,” and emphasising the need
for “three big shifts: the move from analogue to digital, hospital to community, and sickness
to prevention.”
Yet whilst the government promotes digital innovation and remote healthcare solutions,
Independent Aesthetic Practitioners face an increasingly restrictive landscape around
remote prescribing that contradicts these very principles. The result is a two-tier system
that leaves both practitioners and clients struggling with unnecessary barriers to safe,
effective cosmetic treatments.
The Democratic Right to Choice and Economic Opportunity
We live in a democracy where the fundamental right to work, earn a living, and provide
choice to our clients should be protected. Clients deserve autonomy in their healthcare
decisions, including the right to opt for remote prescribing when appropriate. This isn’t
about circumventing safety measures; it’s about recognising that for non-interventional,
elective cosmetic treatments like botulinum toxin injections, remote prescribing can be not
only safe but preferable in many circumstances.
The stability of insurance policies for botulinum toxin treatments reflects the low risk
nature of these procedures. When practitioners maintain appropriate clinical standards and
follow established protocols, remote prescribing offers numerous benefits that current
restrictive policies fail to acknowledge.
The Benefits of Remote Prescribing Choice
Remote prescribing provides clients with the opportunity to make informed decisions in
their own environment, free from the perceived pressure of face-to-face consultations. This
“cooling-off” period allows for more thoughtful consideration of treatment options.
Additionally, infection control protocols and hygiene restrictions that may limit some
clients’ ability to visit clinics is eliminated, making aesthetic treatments more accessible to
everyone.
The technology exists to enable virtual consultations, troubleshooting sessions, and follow-up-
up appointments when in-person visits aren’t practical or possible. Video conferencing,
digital photography, and secure communication platforms provide robust tools for
assessment and ongoing care.
Real Stories: The Human Cost of Restrictive Policies
Case Study 1: Sarah – The Working Mother Caught Between Commitments
Sarah, a 42-year-old marketing executive from Edinburgh, has been receiving botulinum
toxin treatments for migraine relief and facial rejuvenation for three years. Her demanding
work schedule requires frequent travel, and her clinic’s no-children policy means she
cannot bring her young daughter to appointments.
“I’ve been seeing the same practitioner for years. She knows my medical history, my
response to treatment, and my concerns. Yet now I’m told I must take time off work and
arrange childcare every few months just for a five-minute consultation before my routine
treatment. It’s become almost impossible to maintain the treatment schedule that’s been
working perfectly for me.”
Sarah’s situation illustrates how blanket restrictions ignore the reality of established
patient-practitioner relationships and the practical challenges faced by working parents.
Case Study 2: Margaret – The Devoted Carer
Margaret, 58, cares for her elderly mother with dementia in a small town outside Glasgow.
Her mother requires constant supervision, and Margaret can only leave for essential
appointments when her sister travels from Aberdeen – approximately once every six weeks.
“I’ve been having treatments for over five years with the same nurse prescriber. My
mother’s condition means I can’t just pop out for appointments anymore. When I asked
about remote prescribing for my usual treatment, I was told it wasn’t possible. The stress of
arranging care for my mother, combined with the guilt of leaving her, makes something that
should be straightforward incredibly difficult.”
Margaret’s case demonstrates how caring responsibilities can create genuine barriers to
accessing routine treatments, and how remote prescribing could provide a compassionate
solution.
Case Study 3: Emma – The Rural Reality
Emma lives in a coastal village in the Scottish Highlands, 18 miles from the nearest town.
The closest prescriber is 10 miles away, and she doesn’t drive due to a visual impairment.
Public transport is limited to twice weekly, and the journey takes over an hour each way.
“I used to have a mobile practitioner who came to the village, but she moved away. Now I’m
told I need to see someone face-to-face every time, but there’s literally no one within a
reasonable distance who can prescribe. I either have to pay for a taxi, which costs more
than the treatment itself, or go without. It feels like I’m being punished for living rurally.”
The prescriber shortage in rural Scotland creates particular hardships for clients who
cannot easily travel, highlighting the importance of flexible prescribing options.
Case Study 4: James – The Financial Burden
James, a 35-year-old teacher from a small town near Inverness, has been receiving
botulinum toxin treatments for excessive sweating. The nearest prescriber is over 30 miles
away, requiring a day off work and substantial travel costs.
“Between the time off work, petrol, and parking, a simple consultation costs me nearly £100
before I even pay for the treatment. As a teacher, I can’t afford to keep doing this every few
months. I’ve been with the same practitioner for two years – she knows my case inside out.
A video call would be perfectly adequate for assessing whether I need my usual treatment.”
James’s situation demonstrates how geographical barriers can create financial hardship that
makes routine treatments unaffordable, particularly affecting those in lower-paid public
sector roles.
Case Study 5: Sophie – The Holiday Dilemma
Sophie, a 29-year-old from Perth, had planned her regular botulinum toxin appointment
before her wedding. However, a family emergency required her to travel abroad for two
weeks, conflicting with her scheduled face-to-face consultation.
“I’ve been having the same treatment every four months for three years. My wedding is in
six weeks, and I specifically timed my treatment to ensure optimal results. Because I can’t
make the face-to-face appointment, I’m told I’ll have to wait until I return, which will be
too late for my wedding. A video consultation would solve this completely, but I’m told it’s
not allowed.”
Sophie’s case illustrates how rigid policies can impact significant life events, causing
unnecessary stress and disappointment.
The Scottish Context: Regulation Without Representation
Scotland’s approach to aesthetic regulation has been particularly problematic for
independent practitioners. In March 2024, Scotland was found to have the ‘worst aesthetics
regulation’ in Europe. Yet, decisions continue to be made without meaningful consultation
with independent practitioners who form the backbone of the industry.
The economic impact cannot be ignored. Scotland faces a larger proportion of economic
inactivity than the rest of the UK, reflecting both a higher proportion of the population with
long-term conditions and a higher correlation between long-term health conditions and
disabilities and inactivity. Independent aesthetic practitioners contribute significantly to
Scotland’s economy, employing staff, paying taxes, and providing services that support both
physical and mental well-being.
Many practitioners have built successful businesses over the years, investing in training,
equipment, and premises. Restrictive remote prescribing policies threaten these
investments and the livelihoods of practitioners and their employees. This particularly
impacts female entrepreneurs, as the aesthetic industry has provided opportunities for
many women to build independent businesses.
The Scottish Government’s commitment to the regulation of non-surgical cosmetic
treatments, with formal regulations expected by Spring 2026, must include meaningful
consultation with independent practitioners to ensure that regulations support rather than hinder
undermine this vital sector.
Safety First: The Reality of Low-Risk Treatments
Critics of remote prescribing often cite safety concerns, but this ignores the reality of
botulinum toxin treatments. These are not high-risk interventions requiring emergency
medical facilities. The low-risk nature is reflected in stable insurance premiums and the
track record of thousands of successful treatments performed by qualified practitioners.
For practitioners who maintain appropriate clinical standards, remote prescribing for
established clients receiving routine treatments poses minimal additional risk. The key is
ensuring proper training, protocols, and clinical judgment, not blanket prohibitions that
ignore individual circumstances.
Where emergency intervention might be required, practitioners should be permitted to
keep appropriate prescribed medications on-site. This is about client safety and responsive
care, not convenience.
The Threat to Professional Practice
Qualified nurses are being threatened with losing their PIN (Professional Identification
Number) If they engage in remote prescribing for aesthetic treatments. This is not only
unjustifiable but also contradicts the principles of professional autonomy and clinical judgment
that underpin nursing practice.
Nurses undergo extensive training to develop clinical assessment skills and professional
judgment. To suggest they cannot safely assess the suitability of routine treatments for
established clients via digital means undermines their professional competence and
experience.
Common Sense and Clinical Judgment
Remote prescribing is not illegal. It requires appropriate clinical judgment, proper
protocols, and consideration of individual circumstances. For practitioners uncertain about
safe and ethical remote prescribing, the solution is education and support, not blanket
prohibitions.
Common sense must prevail. When a practitioner has an established relationship with a
client, comprehensive medical history, and documented treatment responses, remote
prescribing for routine treatments can be entirely appropriate. The context and individual
circumstances should guide decisions, not rigid policies that ignore clinical reality.
The Public Education Alternative
Rather than penalising honest, hardworking, tax-paying independent practitioners, efforts
should focus on educating the public to make informed choices. There will always be
unscrupulous operators in any field – medicine, dentistry, and aesthetics alike. However,
targeting legitimate practitioners with restrictive policies doesn’t address the real issue of
inadequate consumer awareness.
The proposed “traffic light system” for aesthetic treatments has been criticised as being
developed without practical industry experience. Instead of creating complex categorisation
systems, focus should be on ensuring practitioners operate from licensed premises with
appropriate government-regulated training and ongoing professional development.
Technology as the Solution, Not the Problem
Health Secretary Wes Streeting’s vision of digital transformation in healthcare should
extend to aesthetic practice. The pledge to “make Britain a powerhouse for life sciences and
medical technology” rings hollow when independent practitioners are prevented from using
available technology to improve client access and care.
Virtual consultations, digital photography for assessment, secure communication platforms,
and electronic prescribing systems all have roles to play in modern aesthetic practice. These
tools can enhance safety, improve documentation, and increase accessibility – but only if
practitioners are permitted to use them.
A Call for Proportionate Regulation
The Independent Aesthetic Practitioners calls for proportionate regulation, evidence-based-
based, and developed in consultation with practising professionals. We support:
- Government-regulated training standards as a prerequisite for practice
- Licensed premises requirements for all practitioners
- Continuing Professional Development (CPD) that builds on formal training
- Public education initiatives to promote informed consumer choice
- Technology-enabled practice that improves access and safety
We oppose: - Blanket prohibitions on remote prescribing that ignore clinical judgment
- Threats to professional registration for appropriate clinical practice
- Regulation developed without meaningful industry consultation
- Policies that create unnecessary barriers to safe, effective treatments
- The Path Forward
The aesthetic industry in Scotland and the UK faces a critical juncture. We can choose a path
that embraces digital innovation, supports professional judgment, and prioritises the client
choice and safety. Or we can continue with restrictive policies that create barriers, threaten
livelihoods, and deny clients access to treatments that improve their quality of life.
The choice should be clear. In a democracy, we must protect the right to work, earn a living,
and provide choice to our clients. Remote prescribing, when conducted appropriately,
represents not a threat to safety but an opportunity to improve access, reduce barriers, and
support the kind of digital healthcare transformation that government ministers champion.
It’s time for common sense, clinical judgment, and client choice to prevail over restrictive
policies that serve no one’s interests. The future of aesthetic practice and the well-being of
the clients we serve depend on getting this right.